Chemokine polymorphisms and lymphoma: a pooled analysis

References

• Hartge P, Wang S, Bracci P, Holly E, Devesa S. Non-Hodgkin lymphoma. In: Schottenfeld D, Fraumeni JJ, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006.
   Google Scholar
• Skibola CF, Bracci PM, Halperin E, et al Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS One 2008;3:e2816.
   PubMed Web of Science ®Google Scholar
• Dean M, Jacobson LP, McFarlane G, et al Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res 1999;59:3561–3564.
   PubMed Web of Science ®Google Scholar
• Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999;93:1838–1842.
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 1991;9:617–648.
   PubMed Web of Science ®Google Scholar
• Pease JE, Williams TJ. The attraction of chemokines as a target for specific anti-inflammatory therapy. Br J Pharmacol 2006;147:S212–S221.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675–705.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. Chemokines. Blood 1997;90:909–928.
   PubMed Web of Science ®Google Scholar
• Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143–154.
   PubMed Web of Science ®Google Scholar
• Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001;15:752–756.
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, Bone ND, Stenson MJ, et al Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Mayo Clin Proc 2004;79:318–325.
   PubMed Web of Science ®Google Scholar
• Jones D, O'Hara C, Kraus MD, et al Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000;96:685–690.
   PubMed Web of Science ®Google Scholar
• Trentin L, Cabrelle A, Facco M, et al Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004;104:502–508.
   PubMed Web of Science ®Google Scholar
• Wong S, Fulcher D. Chemokine receptor expression in B-cell lymphoproliferative disorders. Leuk Lymphoma 2004;45:2491–2496.
   PubMed Web of Science ®Google Scholar
• Chang CC, Chen SC, Hsieh YH, et al Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 2009;47:412–418.
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Kikuno N, et al CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res 2007;13:5056–5062.
   PubMed Web of Science ®Google Scholar
• Liou JM, Lin JT, Huang SP, et al RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol 2008;43:115–123.
   PubMed Web of Science ®Google Scholar
• Soria G, Ben-Baruch A. The CCL5/CCR5 axis in cancer. In: Fulton A, editor. Chemokine receptors in cancer. New York: Humana Press; 2009.
   Google Scholar
• Vindrieux D, Escobar P, Lazennec G. Emerging roles of chemokines in prostate cancer. Endocr Relat Cancer 2009;25:25.
   Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, et al Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111:4029–4038.
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Godessart N. Chemokines in autoimmunity: from pathology to therapeutics. Autoimmun Rev 2002;1:313–320.
   PubMedGoogle Scholar
• Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000;85:1648–1657.
   PubMed Web of Science ®Google Scholar
• Mo R, Chen J, Grolleau-Julius A, Murphy HS, Richardson BC, Yung RL. Estrogen regulates CCR gene expression and function in T lymphocytes. J Immunol 2005;174:6023–6029.
   PubMed Web of Science ®Google Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007;28:521–574.
   PubMed Web of Science ®Google Scholar
• Holly EA, Lele C, Bracci PM, McGrath MS. Case–control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 1999;150:375–389.
   PubMed Web of Science ®Google Scholar
• Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004;15:771–780.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112–2135.
   PubMed Web of Science ®Google Scholar
• Faure S, Meyer L, Costagliola D, et al Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000;287:2274–2277.
   PubMed Web of Science ®Google Scholar
• Smith MW, Dean M, Carrington M, et al Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959–965.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263–265.
   PubMed Web of Science ®Google Scholar
• Lake SL, Lyon H, Tantisira K, et al Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56–65.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Ann Rev Immunol 2007;25:787–820.
   PubMed Web of Science ®Google Scholar
• Ivansson EL, Gustavsson IM, Magnusson JJ, et al Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer 2007;121:2451–2457.
   PubMed Web of Science ®Google Scholar
• Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:726–731.
   PubMed Web of Science ®Google Scholar
• Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 2006;25:357–371.
   PubMed Web of Science ®Google Scholar
• Slettenaar VI, Wilson JL. The chemokine network: a target in cancer biology? Adv Drug Deliv Rev 2006;58:962–974.
   PubMedGoogle Scholar
• Chelli M, Alizon M. Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor. J Biol Chem 2001;276:46975–46982.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:405–408.
   PubMed Web of Science ®Google Scholar
• Saenz-Lopez P, Carretero R, Cozar JM, et al Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer 2008;8:382.
   PubMed Web of Science ®Google Scholar
• Al-Abdulhadi SA, Helms PJ, Main M, Smith O, Christie G. Preferential transmission and association of the ‐403 G –> A promoter RANTES polymorphism with atopic asthma. Genes Immun 2005;6:24–30.
   PubMed Web of Science ®Google Scholar
• Nickel RG, Casolaro V, Wahn U, et al Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000;164:1612–1616.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Roberts MH, Yamamoto N, Sugiura H, Uehara M, Hopkin JM. Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis. Int J Immunogenet 2006;33:423–428.
   PubMed Web of Science ®Google Scholar
• Azenshtein E, Luboshits G, Shina S, et al The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 2002;62:1093–1102.
   PubMed Web of Science ®Google Scholar
• Ek S, Bjorck E, Hogerkorp CM, Nordenskjold M, Porwit-MacDonald A, Borrebaeck CA. Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival. Int J Cancer 2006;118:2092–2097.
   PubMed Web of Science ®Google Scholar
• Fischer M, Juremalm M, Olsson N, et al Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer 2003;107:197–201.
   PubMed Web of Science ®Google Scholar
• Payne AS, Cornelius LA. The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 2002;118:915–922.
   PubMed Web of Science ®Google Scholar
• Adler EP, Lemken CA, Katchen NS, Kurt RA. A dual role for tumor-derived chemokine RANTES (CCL5). Immunol Lett 2003;90:187–194.
   PubMed Web of Science ®Google Scholar
• Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol 2009;182:3945–3946.
   PubMed Web of Science ®Google Scholar
• Lucotte G. Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis. Infect Genet Evol 2002;1:201–205.
   PubMed Web of Science ®Google Scholar
• Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes 2005;54:3331–3335.
   PubMed Web of Science ®Google Scholar
• Fischer A, Valentonyte R, Nebel A, et al Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Lofgren's syndrome. J Mol Med 2008;86:553–561.
   PubMed Web of Science ®Google Scholar